As part of our series focussing on medicines in Australia, we have added a product review of the use of natalizumab in relapsing/remitting multiple sclerosis.
This review discusses indications and dosage, contraindications and a series of clinical studies featuring natalizumab use to treat relapsing/remitting multiple sclerosis. It provides commentary from Dr Lesley-Ann Hall, a Senior Consultant Neurologist at Flinders Medical Centre in South Australia.
Please login below to download this issue (PDF)